Hydrochloric Acid

Hydrochloric Acid

SCHEMBL3008147

CC1=CC(C)(C)c2cc3c(cc21)-c1cc2c(cc1C3[Zr+2](C1=C(C)C(CC34CC5CC(CC(C5)C3)C4)=CC1C)=C(c1ccc(C(C)(C)C)cc1)c1ccc(C(C)(C)C)cc1)C(C)(C)C=C2C.[Cl-].[Cl-]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1838664-B1 MANUFACTURE PROCESS OF N-SUBSTITUTED SALICYLAMIDES NOVARTIS AG (CH) 2015-07-15 EP disclosed
US-8461385-B2 Manufacture process of organic compounds NOVARTIS AG (CH) 2013-06-11 US disclosed
US-20100190941-A1 TRANSITION METAL COMPOUND, CATALYST FOR OLEFIN POLYMERIZATION, AND PROCESS FOR PRODUCING OLEFIN POLYMER MITSUI CHEMICALS, INC. 2010-07-29 US disclosed
US-20090253811-A1 MANUFACTURE PROCESS OF ORGANIC COMPOUNDS NOVARTIS AG (CH) 2009-10-08 US disclosed
EP-1900744-A1 TRANSITION METAL COMPOUND, OLEFIN POLYMERIZATION CATALYST, AND PROCESS FOR PRODUCING OLEFIN POLYMER Mitsui Chemicals, Inc. (JP) 2008-03-19 EP disclosed
EP-1838664-A1 MANUFACTURE PROCESS OF N-SUBSTITUTED SALICYLAMIDES Novartis AG (CH) 2007-10-03 EP disclosed
WO-2006063821-A1 MANUFACTURE PROCESS OF N-SUBSTITUTED SALICYLAMIDES NOVARTIS AG (CH) 2006-06-22 WO disclosed